Kim, Hwanik; Jung, Gyoohwan; Kim, Jin Hyuck; Byun, Seok-Soo; Hong, Sung Kyu
Scientific reports
2021Aug ; 11 ( 1 ) :17447.
PMID : 34465825
ÀúÀÚ »ó¼¼Á¤º¸
Kim, Hwanik -
Jung, Gyoohwan -
Kim, Jin Hyuck -
Byun, Seok-Soo -
Hong, Sung Kyu -
ABSTRACT
We evaluated the role of prostate health index (PHI) in predicting Gleason score (GS) upgrading in International Society of Urological Pathology Grade Group (ISUP GG) 1 & 2 prostate cancer (PCa) or adverse pathologic outcomes at radical prostatectomy (RP). A total of 300 patients with prostate specific antigen ¡Ã 3 ng/mL, PHI and prostate biopsy (71 patients with RP included) were retrospectively included in the study. The primary study outcomes are PCa and clinically significant PCa (csPCa, defined as ISUP GG ¡Ã 2) diagnostic rate of PHI, and GS upgrading rate at RP specimen. The secondary outcomes are the comparison between GS upgrading and non-upgrading group, GS upgrading and high-risk PCa (ISUP GG ¡Ã 3 or ¡Ã pT3a) predictability of preoperative clinical factors. Overall, 139 (46.3%) and 92 (30.7%) were diagnosed with PCa and csPCa, respectively. GS upgrading rate was 34.3% in all patients with RP. Significant differences were shown in the total prostate volume (p = 0.047), the distribution of ISUP GG at biopsy (p = 0.001) and RP (p = 0.032), respectively. PHI values ¡Ã 55 [Odds ratio (OR): 3.64 (95% confidence interval (CI) = 1.05-12.68, p = 0.042] and presence of PI-RADS lesion ¡Ã 4 (OR: 7.03, 95% CI = 1.68-29.51, p = 0.018) were the significant predictors of GS upgrading in RP specimens (AUC = 0.737). PHI values ¡Ã 55 (OR: 9.05, 5% CI = 1.04-78.52, p = 0.046) is a significant factor for predicting adverse pathologic features in RP specimens (AUC = 0.781). PHI could predict GS upgrading in combination with PIRADS lesions ¡Ã 4 in ISUP GG 1 & 2. PHI alone could evaluate the possibility of high-risk PCa after surgery as well.
keyword
na
¸µÅ©